• Kai Beeh and Wisia Wedzicha

Kai Beeh

Dr Beeh was born in Cuxhaven, Germany. After studies in Medicine and Art History in Frankfurt, Germany, he was clinically trained at Mainz University Hospital, Mainz, Germany, from 1997 to 2004. He performed basic research studies on lung inflammation at the National Heart and Lung Institute, Imperial College London, London, UK, in 2000, and received board certifications in Internal Medicine (2003) and Pulmonary Medicine (2004). Dr Beeh further received a degree in healthcare “Market Access Management” from the European Business School, Oestrich Winkel, in 2015.

In 2004, Dr Beeh founded the insaf Respiratory Research Institute in Wiesbaden, Germany a privately owned clinical research facility, where he also holds the position of Medical Director. After receiving the venia legendi for Internal Medicine from the medical faculty of the University of Mainz, Germany in 2004, he also serves as external lecturer (‘Privatdozent’/adjunct Professor) at Mainz University Hospital. Dr Beeh has designed and conducted more than 100 clinical trials in asthma, chronic obstructive pulmonary disease (COPD) and allergy, acting as Principal or Coordinating Investigator. In 2009, he founded AEREON Consulting, a clinical service company, located in Wiesbaden, Germany. Dr Beeh is a member of the European Respiratory Society, German Society of Pneumology, German Society for Market Access and Association of German Allergists.

Dr Beeh is Editor of Pulmonary Therapy, Associate Editor of Advances in Therapy and has published or co-authored over 85 peer-reviewed articles on pathophysiology and pharmacotherapy of chronic airway diseases, including two publications in the New England Journal of Medicine. He has also edited and co-authored a textbook on COPD exacerbations in 2014, and reviews scientific articles for biomedical journals such as the European Respiratory Journal, Lancet Respiratory Medicine, and others.

Wisia Wedzicha 

Wisia Wedzicha is Professor of Respiratory Medicine at the National Heart and Lung Institute, Imperial College, UK and Head of the Respiratory Division. She qualified from Somerville College, Oxford University and St Bartholomew’s Hospital Medical College, University of London. She was elected as Fellow of the Academy of Medical Sciences (FMedSci) in 2013 and is an National Institute of Health Research (NIHR) Senior Investigator. She has received the Fellowship of the ERS (FERS) and also the ATS (ATSF).  She received the Helmholtz International Fellow Award in 2014.

Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic.

Professor Wedzicha chaired the English Department of the Health Home Oxygen Clinical User Group, and was a member of the Guideline Development Group for the revision of the National Institute for Healthcare and Clinical Excellence COPD Guidelines. In 2016, she has been appointed as an Expert Adviser to the NICE Centre for Clinical Practice.

Professor Wedzicha was Editor-in-Chief of Thorax from 2002 to 2010, and is a member of the BioMed Central advisory board. She is currently Editor in Chief for the American Journal of Respiratory and Critical Care Medicine. In addition, she is on the editorial boards of a number of international journals. She was  the Lancet Ombudsman till 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.